- Patent Title: Composition for preventing and treating acetaminophen inducing hepatotoxicity containing TNP(N2-(m-Trifluorobenzyl), N6-(p-nitrobenzyl)purine) as an effective ingredient
-
Application No.: US15032295Application Date: 2015-07-03
-
Publication No.: US09636343B2Publication Date: 2017-05-02
- Inventor: Seyun Kim , Yong-Mahn Han , Young-Ran Kim , Seulgi Lee
- Applicant: Korea Advanced Institute of Science and Technology
- Applicant Address: KR Daejeon
- Assignee: KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
- Current Assignee: KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
- Current Assignee Address: KR Daejeon
- Agency: Lathrop & Gage LLP
- Priority: KR10-2015-0022315 20150213; KR10-2015-0088220 20150622
- International Application: PCT/KR2015/006876 WO 20150703
- International Announcement: WO2016/129760 WO 20160818
- Main IPC: A61K31/52
- IPC: A61K31/52

Abstract:
The present invention relates to a composition for the prevention and treatment of liver toxicity originated from acetaminophen comprising TNP (N2-(m-Trifluorobenzyl), N6-(p-nitrobenzyl)purine) as an active ingredient. The present inventors confirmed that TNP known as a 5-inosito pyrophosphate inhibitor suppressed apoptosis caused by acetaminophen in human embryonic stem cell-derived liver cells, mouse liver cells, and human hepatoma cell lines, up-regulated glutathione converted in liver cells, and inhibited JNK phosphorylation that is a kind of response against stress increased by acetaminophen. The inventors further confirmed that TNP had the activity of protecting liver cells from the toxicity caused by acetaminophen in an animal model. Therefore, TNP can be efficiently used as an active ingredient for a composition for the prevention and treatment of liver toxicity caused by acetaminophen.
Public/Granted literature
Information query
IPC分类: